Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpa Shahani

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biomaterials|August 30, 2005
Biodegradable and photocrosslinkable polyphosphoester hydrogelQiang Li, Jun Wang, Shilpa Shahani, et al.
Oncoimmunology|January 25, 2021
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastomaSoheila Shirinbak, Randall Y Chan, Shilpa Shahani, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicityJennifer Jess, Bonnie Yates, Alina Dulau-Florea, et al.
American Journal of Hematology|March 7, 2023
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusionsIbrahim Aldoss, Michelle Afkhami, Dongyun Yang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biomaterials|August 30, 2005
Biodegradable and photocrosslinkable polyphosphoester hydrogelQiang Li, Jun Wang, Shilpa Shahani, et al.
Oncoimmunology|January 25, 2021
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastomaSoheila Shirinbak, Randall Y Chan, Shilpa Shahani, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicityJennifer Jess, Bonnie Yates, Alina Dulau-Florea, et al.
American Journal of Hematology|March 7, 2023
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusionsIbrahim Aldoss, Michelle Afkhami, Dongyun Yang, et al.
Pageof 1